December 22, 2015 |
Advent International-owned biopharmaceutical firm Grupo Biotoscana has bought Argentina’s Laboratorio LKM, the private equity fund said. Advent previously owned a controlling stake in LKM.
The new entity, with combined revenues of $250m, will o
Private equity-owned biopharmaceuticals unit Grupo Biotoscana will merge with Laboratorio LKM